Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1999-1-4
|
| pubmed:abstractText |
X-linked nephrogenic diabetes insipidus (NDI) is a rare disease with defective renal and extrarenal arginine vasopressin V2 receptor responses due to mutations in the AVPR2 gene in Xq28. To study the cause of loss of function of mutant V2 receptors, we expressed 12 mutations (N55H, L59P, L83Q, V88M, 497CC-->GG, deltaR202, I209F, 700delC, 908insT, A294P, P322H, P322S) in COS-7 cells. Eleven of these, including P322H, were characterized by a complete loss of function, but the mutation P322S demonstrated a mild clinical and in vitro phenotype. This was characterized by a late diagnosis without any growth or developmental delay and a significant increase in urine osmolality after intravenous 1-deamino[D-Arg8]AVP administration. In vitro, the P322S mutant was able to partially activate the Gs/adenylyl cyclase system in contrast to the other V2R mutants including P322H, which were completely inactive in this regard. This showed not only that Pro 322 is important for proper V2R coupling, but also that the degree of impairment is strongly dependent on the identity of the substituting amino acid. Three-dimensional modeling of the P322H and P322S mutant receptors suggested that the complete loss of function of the P322H receptor could be due, in part, to hydrogen bond formation between the His 322 side chain and the carboxyl group of Asp 85, which does not occur in the P322S receptor.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1046-6673
|
| pubmed:author |
pubmed-author:AklMM,
pubmed-author:AlonsoGG,
pubmed-author:AntignacCC,
pubmed-author:ArthusM FMF,
pubmed-author:BalestreM NMN,
pubmed-author:BarberisCC,
pubmed-author:BichetD GDG,
pubmed-author:CotteNN,
pubmed-author:DéchauxMM,
pubmed-author:HendyG NGN,
pubmed-author:HibertMM,
pubmed-author:JardSS,
pubmed-author:LonerganMM,
pubmed-author:MorinDD,
pubmed-author:MouillacBB,
pubmed-author:SabatierNN,
pubmed-author:TurnerM SMS,
pubmed-author:VargasRR
|
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1861-72
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9773787-Blotting, Western,
pubmed-meshheading:9773787-Cell Membrane,
pubmed-meshheading:9773787-Cells, Cultured,
pubmed-meshheading:9773787-Diabetes Insipidus, Nephrogenic,
pubmed-meshheading:9773787-European Continental Ancestry Group,
pubmed-meshheading:9773787-Female,
pubmed-meshheading:9773787-Humans,
pubmed-meshheading:9773787-Kidney,
pubmed-meshheading:9773787-Male,
pubmed-meshheading:9773787-Microscopy, Electron,
pubmed-meshheading:9773787-Microscopy, Fluorescence,
pubmed-meshheading:9773787-Models, Molecular,
pubmed-meshheading:9773787-Mutation,
pubmed-meshheading:9773787-Pedigree,
pubmed-meshheading:9773787-Phenotype,
pubmed-meshheading:9773787-Receptors, Vasopressin,
pubmed-meshheading:9773787-Sensitivity and Specificity,
pubmed-meshheading:9773787-Sequence Homology, Amino Acid
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.
|
| pubmed:affiliation |
Unité Institut National de la Santé et de la Recherche Médicale (INSERM) 469, Centre National de la Recherche Scientifique-INSERM de Pharmacologie-Endocrinologie, Montpellier, France.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|